Pacific Biosciences of California Inc. PACB) on Thursday reported a loss of $60.7 million in its third quarter.

On a per-share basis, the Stamford, Connecticut-based company said it had net income of $5.32. Earnings, adjusted for one-time gains and costs, came to $2.50 per share. The results exceeded Wall ...

We integrate fundamentals into methodology to provide comprehensive market context, revealing high-probability price targets ...

Vertical Analysis involves expressing each item in financial statements as a percentage of a base figure, making comparisons easier. For instance, each expense in an income statement might be ...

Here is a snapshot of the index over the past 5 days: Here is a snapshot of the index from the past six months with a 50-day moving average: The U.S. Treasury put the closing yield on the 10-year ...

The standing of CVB Financial among financial experts is revealed through an in-depth exploration of recent analyst actions.

The beauty products company posted revenue of $3.36 billion in the period, missing Street forecasts. Eleven analysts surveyed by Zacks expected $3.37 billion. For the current quarter ending in ...

The technology information and analysis company posted revenue of $1.48 billion in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $1.47 billion.